Lyu In Jeong, Park Kyung-Ah, Oh Sei Yeul
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Ophthalmology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
BMC Ophthalmol. 2017 Dec 12;17(1):247. doi: 10.1186/s12886-017-0644-7.
To evaluate the manifestations of increased esodeviation under cycloplegia with 0.5% tropicamide and 0.5% phenylephrine in children with hyperopia and esotropia.
We reviewed the medical record of 34 children with hyperopia and esotropia who underwent a prism alternate cover test before and after instillation of mixed eye drops containing 0.5% tropicamide and 0.5% phenylephrine between November 2014 and October 2015. Increased angle of deviation was defined as 10 prism diopters (PD) or greater deviation after cycloplegia. The factors related to increased angle of deviation were evaluated using univariable and multivariable logistic regression analysis.
The median age was 5.0 years (interquartile range, 3.75 to 5.0) and 12 patients (35.3%) were male. The median manifested refractive (MR) was +2.13 diopters (D) (+0.92 to +4.47) and cycloplegic refractive (CR) was +3.50 D (+1.72 to +5.66). The median difference between MR and CR was +0.88 D (+0.50 to +1.28). Thirteen patients (38.2%) showed increased esodeviation under cycloplegia and all had accommodative esotropia. A larger difference between MR and CR was the only significant factor affecting increased esodeviation in both univariable (OR = 4.72, P = 0.029) and multivariable (OR = 5.22, P = 0.047) analyses.
Children with hyperopia and esotropia often showed an increased angle of deviation after instillation of 0.5% tropicamide and 0.5% phenylephrine. This phenomenon reminded the clinicians that cycloplegics can have a different effect on esodeviation and suggested that increased angle of esodeviation may help to reveal the latent deviation in some patients with hyperopia and esotropia.
评估0.5%托吡卡胺和0.5%去氧肾上腺素散瞳下远视性内斜视儿童内斜度增加的表现。
回顾2014年11月至2015年10月间34例远视性内斜视儿童的病历,这些儿童在滴入含0.5%托吡卡胺和0.5%去氧肾上腺素的混合眼药水前后均接受了棱镜交替遮盖试验。斜视度增加定义为散瞳后斜视度增加10棱镜度(PD)或更大。使用单变量和多变量逻辑回归分析评估与斜视度增加相关的因素。
中位年龄为5.0岁(四分位间距,3.75至5.0),12例患者(35.3%)为男性。平均显性屈光不正(MR)为+2.13屈光度(D)(+0.92至+4.47),散瞳验光屈光不正(CR)为+3.50 D(+1.72至+5.66)。MR与CR的中位差值为+0.88 D(+0.50至+1.28)。13例患者(38.2%)在散瞳下表现为内斜度增加,均为调节性内斜视。在单变量(OR = 4.72,P = 0.029)和多变量(OR = 5.22,P = 0.047)分析中,MR与CR之间的较大差值是影响内斜度增加的唯一显著因素。
远视性内斜视儿童在滴入0.5%托吡卡胺和0.5%去氧肾上腺素后常出现斜视度增加。这种现象提醒临床医生,散瞳剂对内斜视可能有不同影响,并提示内斜度增加可能有助于揭示一些远视性内斜视患者的潜在斜视。